Influence of HLA-DQA1*05 Genotype in Adults With Anti-TNF Treatment With Proactive Therapeutic Drug Monitoring.

计划入组 280 人 · 首次发布于 2023 年 8 月 14 日

A PHASE III, RANDOMIZED, OPEN-LABEL ACTIVE COMPARATOR?CONTROLLED MULTICENTER STUDY TO EVALUATE EFFICACY AND SAFETY OF OBINUTUZUMAB IN PATIENTS WITH PRIMARY MEMBRANOUS NEPHROPATHY

计划入组 0 人

Blinatumomab Plus HLA-Mismatched Cellular Therapy for Relapsed/Refractory CD19+ ALL

计划入组 22 人 · 首次发布于 2018 年 11 月 23 日

ATR-05

AD-05

AT-05

Bayer Pharma AG

Germany

蚌埠泰格药业有限公司

Essity Hygiene and Health AB

Sweden

Prometheus Laboratories Unveils Groundbreaking Pre-Therapy Test for IBD Biologic Response Prediction

Chinese Researchers Discover Novel HLA Allele HLA-DQB1*03:03:38 with Clinical Promise

Axsome's AXS-05 Shows Promise in Alzheimer's Agitation Trials, NDA Submission Planned for 2025